Success of mineral trioxide aggregate in pulpotomized primary molars

Journal of Clinical Pediatric Dentistry

Volumn 29, Issue 4, 2005, Pages 307-311

  Farsi, Najat ^a   Alamoudi, Najlaa ^a   Balto, Khalid ^a   Mushayt, Abdullah ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM DERIVATIVE; BIOMATERIAL; CALCIUM DERIVATIVE; FORMOCRESOL; MINERAL TRIOXIDE AGGREGATE; OXIDE; SILICATE;

ARTICLE; CHI SQUARE DISTRIBUTION; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECIDUOUS TOOTH; DRUG COMBINATION; DRUG EFFECT; ENDODONTICS; HUMAN; METHODOLOGY; MOLAR TOOTH; PRESCHOOL CHILD; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL;

ALUMINUM COMPOUNDS; BIOCOMPATIBLE MATERIALS; CALCIUM COMPOUNDS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; FORMOCRESOLS; HUMANS; MOLAR; OXIDES; PULPOTOMY; SILICATES; TOOTH, DECIDUOUS;

EID: 27744540800     PISSN: 10534628     EISSN: None     Source Type: Journal    
DOI: 10.17796/jcpd.29.4.n80t77w625118k73     Document Type: Article

References (33)

1. Margolis MQ, Hunt RJ, Vann WF, Stewart PW. Distribution of primary tooth caries in first-grade children from 2 non-flluoridated US communities. Pediatr Dent 16: 200-205, 1994.
2. Primosch RE, Glom TA, Jerrel RG. Primary tooth pulp therapy as taught in predoctoral pediatric dental programs in the United States. Pediatr Dent 19: 118-122, 1997.
3. Judd PL, Kenny DJ. Formocresol concerns, a review. J Can Dent Assoc 53: 401-4, 1987.
4. Hunter ML, Hunter B. Vital pulpotomy in the primary dentition: attitudes and practices on specialists in paediatric dentistry practicing in the United Kingdom. Int J Paediatr Dent 13: 246-250, 2003.
5. Sun HW, Feigal RJ, Messer HH. Cytotoxicity of gluteraldehyde and formaldehyde in relation to time of exposure and concentration. Pediatr Dent 12: 303-7, 1990.
6. Schroder U. A 2-year old follow-up of primary pulpotomized with a gentle technique and capped with calcium hydroxide Scand J Dent Res 86: 273-78, 1978.
7. Magnusson BO. Therapeutic pulpotomy in primary molars-clinical and histological follow-up. II. Zinc oxide eugenol as wound dressing. Odontol Rev 22: 45-54, 1971.
8. Shulman ER, McIver FT, Burkes EJ. Comparisons of electrosurgery and formocresol as pulpotomy techniques in monkey primary teeth. Pediatr Dent 9: 189-94, 1987.
9. Rivera N, Reyes E, Mazzaoui S, Moron A. Pulpal therapy for primary teeth: formocresol vs electrosurgery clinical study. J Dent Child 70: 71-73, 2003.
10. Shoji S, Nakamura M, Horiuchi H. Histopathological changes in dental pulps irredicted by CO2 laser. A preliminary report on laser pulpotomy. J Endodont 11: 379-84, 1985.
11. Landan MJ, Johnsen DC. Pulpal response to ferric sulfate in monkeys. J Dent Res 67: 215, 1988.
12. Fei AL, Udin RD, Johnson R. A clinical study of ferric sulphate as a pulpotomy agent in primary teeth. Pediatr Dent 13: 327-32, 1991.
13. Burnett S, Walker J. Comparison of ferric sulfate, formocresol, and a combination of ferric sulfate/formocresol in primary tooth vital pulpotomies: a retrospective radiographic survey. J Dent Child 69: 44-8, 12, 2002.
14. Casas M, Kenny D, Johnston D, Judd P. Long-term outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatr Dent 26: 41-47, 2004.
15. Fadavi S, Anderson AW, Punwani IC. Freeze-dried bone in pulpotomy procedures in monkeys. J Pedod 13: 108-22, 1989.
16. Fadavi S, Anderson AW. A comparison of the pulpal response to freeze-dried bone, calcium hydroxide, and zinc oxide-eugenol in primary teeth in two cynomolgus monkeys. Pediatr Dent 18: 52-56, 1996.
17. Nakashima M. The induction of reparative dentine in the amputated dental pulp of the dog bone morphogenetic protein. Arch Oral Biol 35: 493-97, 1990.
18. Nakashima M. Induction of dentine formation on canine amputated pulp by recombinant human bone morphogenic proteins. (BMP)-2 and 4. J Dent Res 73: 1515-22, 1994.
19. Rutherford RB, Wahle J, Tucker M, Roger D, Charette M. Induction of reparative dentine formation in monkeys by recombinant human osteogenic protein -1. Arch Oral Biol 38: 571-76, 1993.
20. Torabinejad M, Hong CU, McDonald F, Pitt Ford TR. Physical and chemical properties of a new root-end filling material. J Endod 21: 349-353, 1995.
21. Schwarz R, Mauger M, Clement D, Walker W. Mineral trioxide aggregate: a new material for endodontics. JADA 130: 967-975, 1999.
22. Mitchell PJ, Pitt Ford TR, Torabinejad M, McDonald F. Osteoblast biocompatibility of mineral trioxide aggregate. Biomaterial 20: 167-173, 1999.
23. Zhu Q, Haglund R, Safavi KE, Spangberg LSW. Adhesion of human osteoblasts on root-end filing material. J Endodont 26: 404-406, 2000.
24. Tziafas D, Pantelidon O, Alvanon A, Belibasakis G, Papadimitriou S. The dentinogenic effect of mineral trioxide aggregate (MTA) in short-term capping experiments. Int Endod J 35: 245-54, 2002.
25. Pitt Ford T, Torabinejad M, Abedi, H, Bakland LK, Kariyawasan SP. Using mineral trioxide aggregate as pulp capping material. JADA 127: 1491-1494, 1996.
26. Weldon JK, Pashley DH, Loushine RJ, Weller RN, Kimbrough WF. Sealing ability of mineral trioxide aggregate and super-EBA when used as furcation repair materials: a longitudinal study. J Endodont 28: 467-70, 2002.
27. Sluyk S, Moon P, Hartwell G. Evaluation of setting properties and retention characteristics of MTA when used as a furcation perforation repair material. J Endodont 24: 768-771, 1998.
28. Torabinejad M, Chivian N. Clinical applications of mineral trioxide aggregate. J Endodont 25: 197-205, 1999.
29. O'Sullivan, Hartwell GR. Obturation of a retained primary mandibular second molar using mineral trioxide aggregate: a case report. J Endodont 27: 703-5, 2001.
30. Eidelman E, Holan G, Fuks A. Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatr Dent 23: 15-18, 2001.
31. Lewis BB, Chestner SB. Formaldehayde in dentistry: a review of mutagenic and carcinogenic potential. JADA 103: 429-434, 1981.
32. Block RM, Lewis, R.D, Hirsch J, Coffey J, Langeland K. Systemic distribution of 14C-labeIed paraformaldehyde incorporated within formocresol for lowing pulpotomies in dogs. J Endodont 9: 176-189, 1983.
33. Vij R, Coll JA, Shelton P, Farooq NS. Caries control and other variables associated with success of primary molar vital pulp therapy. Pediatr Dent 26: 214-20, 2004.